Roles of Oxytocin Neurones in the Control of Stress, Energy Metabolism, and Social Behaviour

Journal of Neuroendocrinology

Volumn 24, Issue 4, 2012, Pages 587-598

  Onaka, T ^a   Takayanagi, Y ^a   Yoshida, M ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Food intake; Noradrenaline; Oxytocin; Prolactin releasing peptide; Serotonin; Social recognition; Stress

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ OCTAPEPTIDE; GHRELIN; NEUROPEPTIDE Y; OXYTOCIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA;

ANOREXIA; ANXIETY; CATECHOLAMINE NERVE CELL; CHRONIC STRESS; ENDURANCE TRAINING; ENERGY CONSUMPTION; ENERGY METABOLISM; FEAR; FOOD INTAKE; FOOD PREFERENCE; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HYPERPHAGIA; HYPERTHERMIA; HYPOTHALAMUS; INTESTINE TRANSIT TIME; NERVE CELL STIMULATION; NEUROMODULATION; NONHUMAN; NORADRENERGIC SYSTEM; OXYTOCIN BLOOD LEVEL; OXYTOCIN RELEASE; PLASMA OSMOLALITY; PRIORITY JOURNAL; REVIEW; SATIETY; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIAL BEHAVIOR; STIMULUS RESPONSE; STRESS; TRANQUILIZING ACTIVITY;

ADAPTATION, PSYCHOLOGICAL; AMYGDALA; ANIMALS; ENERGY METABOLISM; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MODELS, NEUROLOGICAL; NEURAL PATHWAYS; NEURONS; OXYTOCIN; RAPHE NUCLEI; RECEPTORS, OXYTOCIN; SOCIAL BEHAVIOR; SOLITARY NUCLEUS; STRESS, PSYCHOLOGICAL;

EID: 84858833689     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2012.02300.x     Document Type: Review

References (159)

1. Nielsen NR, Kristensen TS, Schnohr P, Grønbaek M. Perceived stress and cause-specific mortality among men and women: results from a prospective cohort study. Am J Epidemiol 2008; 168: 481-496.
2. Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton J, Hoppin JA, Koenig KL, Lee IM, Linet MS, Park Y, Pocobelli G, Schatzkin A, Sesso HD, Weiderpass E, Willcox BJ, Wolk A, Zeleniuch-Jacquotte A, Willett WC, Thun MJ. Body-mass index and mortality among 1.46 million white adults. N Engl J Med 2010; 363: 2211-2219.
3. Liu L. Social connections, diabetes mellitus, and risk of mortality among white and African-American adults aged 70 and older: an eight-year follow-up study. Ann Epidemiol 2011; 21: 26-33.
4. Nyberg ST, Heikkilä K, Fransson EI, Alfredsson L, De Bacquer D, Bjorner JB, Bonenfant S, Borritz M, Burr H, Casini A, Clays E, Dragano N, Erbel R, Geuskens GA, Goldberg M, Hooftman WE, Houtman IL, Jöckel KH, Kittel F, Knutsson A, Koskenvuo M, Leineweber C, Lunau T, Madsen IE, Hanson LL, Marmot MG, Nielsen ML, Nordin M, Oksanen T, Pentti J, Rugulies R, Siegrist J, Suominen S, Vahtera J, Virtanen M, Westerholm P, Westerlund H, Zins M, Ferrie JE, Theorell T, Steptoe A, Hamer M, Singh-Manoux A, Batty GD, Kivimäki M; for the IPD-Work Consortium. Job strain in relation to body mass index: pooled analysis of 160000 adults from 13 cohort studies. J Intern Med 2011; doi:.
5. Dallman MF. Stress-induced obesity and the emotional nervous system. Trends Endocrinol Metab 2010; 21: 159-165.
6. Kawakami A, Okada N, Rokkaku K, Honda K, Ishibashi S, Onaka T. Leptin inhibits and ghrelin augments hypothalamic noradrenaline release after stress. Stress 2008; 11: 363-369.
7. Lauder W, Mummery K, Jones M, Caperchione C. A comparison of health behaviours in lonely and non-lonely populations. Psychol Health Med 2006; 11: 233-245.
8. Horsten M, Mittleman MA, Wamala SP, Schenck-Gustafsson K, Orth-Gomér K. Social relations and the metabolic syndrome in middle-aged Swedish women. J Cardiovasc Risk 1999; 6: 391-397.
9. Ey E, Leblond CS, Bourgeron T. Behavioral profiles of mouse models for autism spectrum disorders. Autism Res 2011; 4: 5-16.
10. Takayanagi Y, Fujita E, Yu Z, Yamagata T, Momoi MY, Momoi T, Onaka T. Impairment of social and emotional behaviors in Cadm1-knockout mice. Biochem Biophys Res Commun 2010; 396: 703-708.
11. Onaka T. Neural pathways controlling central and peripheral oxytocin release during stress. J Neuroendocrinol 2004; 16: 308-312.
12. Sanders G, Freilicher J, Lightman SL. Psychological stress of exposure to uncontrollable noise increases plasma oxytocin in high emotionality women. Psychoneuroendocrinology 1990; 15: 47-58.
13. Pierrehumbert B, Torrisi R, Laufer D, Halfon O, Ansermet F, Beck Popovic M. Oxytocin response to an experimental psychosocial challenge in adults exposed to traumatic experiences during childhood or adolescence. Neuroscience 2010; 166: 168-177.
14. Tabak BA, McCullough ME, Szeto A, Mendez AJ, McCabe PM. Oxytocin indexes relational distress following interpersonal harms in women. Psychoneuroendocrinology 2011; 36: 115-122.
15. Taylor SE, Saphire-Bernstein S, Seeman TE. Are plasma oxytocin in women and plasma vasopressin in men biomarkers of distressed pair-bond relationships? Psychol Sci 2010; 21: 3-7.
16. Marazziti D, Dell'Osso B, Baroni S, Mungai F, Catena M, Rucci P, Albanese F, Giannaccini G, Betti L, Fabbrini L, Italiani P, Del Debbio A, Lucacchini A, Dell'Osso L. A relationship between oxytocin and anxiety of romantic attachment. Clin Pract Epidemiol Ment Health 2006; 2: 28.
17. Holt-Lunstad J, Birmingham W, Light KC. The influence of depressive symptomatology and perceived stress on plasma and salivary oxytocin before, during and after a support enhancement intervention. Psychoneuroendocrinology 2011; 36: 1249-1256.
18. Hoge EA, Pollack MH, Kaufman RE, Zak PJ, Simon NM. Oxytocin levels in social anxiety disorder. CNS Neurosci Ther 2008; 14: 165-170.
19. Purba JS, Hoogendijk WJ, Hofman MA, Swaab DF. Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch Gen Psychiatry 1996; 53: 137-143.
20. Meynen G, Unmehopa UA, Hofman MA, Swaab DF, Hoogendijk WJG. Hypothalamic oxytocin mRNA expression and melancholic depression. Mol Psychiatry 2007; 12: 118-119.
21. Parker KJ, Kenna HA, Zeitzer JM, Keller J, Blasey CM, Amico JA, Schatzberg AF. Preliminary evidence that plasma oxytocin levels are elevated in major depression. Psychiatry Res 2010; 178: 359-362.
22. Frasch A, Zetzsche T, Steiger A, Jirikowski GF. Reduction of plasma oxytocin levels in patients suffering from major depression. Adv Exp Med Biol 1995; 395: 257-258.
23. Ozsoy S, Esel E, Kula M. Serum oxytocin levels in patients with depression and the effects of gender and antidepressant treatment. Psychiatry Res 2009; 169: 249-252.
24. Heim C, Young LJ, Newport DJ, Mletzko T, Miller AH, Nemeroff CB. Lower CSF oxytocin concentrations in women with a history of childhood abuse. Mol Psychiatry 2009; 14: 954-958.
25. Jokinen J, Chatzittofis A, Hellström C, Nordström P, Uvnäs-Moberg K, Asberg M. Low CSF oxytocin reflects high intent in suicide attempters. Psychoneuroendocrinology 2012; 37: 482-490.
26. Heinrichs M, Baumgartner T, Kirschbaum C, Ehlert U. Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol Psychiatry 2003; 54: 1389-1398.
27. Cyranowski JM, Hofkens TL, Frank E, Seltman H, Cai HM, Amico JA. Evidence of dysregulated peripheral oxytocin release among depressed women. Psychosom Med 2008; 70: 967-975.
28. Altemus M, Redwine LS, Leong YM, Frye CA, Porges SW, Carter CS. Responses to laboratory psychosocial stress in postpartum women. Psychosom Med 2001; 63: 814-821.
29. Hew-Butler T, Noakes TD, Soldin SJ, Verbalis JG. Acute changes in endocrine and fluid balance markers during high-intensity, steady-state, and prolonged endurance running: unexpected increases in oxytocin and brain natriuretic peptide during exercise. Eur J Endocrinol 2008; 159: 729-737.
30. Chicharro JL, Hoyos J, Bandres F, Gomez GF, Perez M, Lucia A. Plasma oxytocin during intense exercise in professional cyclists. Horm Res 2001; 55: 155-159.
31. Altemus M, Roca C, Galliven E, Romanos C, Deuster P. Increased vasopressin and adrenocorticotropin responses to stress in the midluteal phase of the menstrual cycle. J Clin Endocr Metab 2001; 86: 2525-2530.
32. Hada T, Onaka T, Takahashi T, Hiraga A, Yagi K. Effects of novelty stress on neuroendocrine activities and running performance in thoroughbred horses. J Neuroendocrinol 2003; 15: 638-648.
33. Bakos J, Hlavacova N, Makatsori A, Tybitanclova K, Zorad S, Hinghofer-Szalkay H, Johansson BB, Jezova D. Oxytocin levels in the posterior pituitary and in the heart are modified by voluntary wheel running. Regul Pept 2007; 139: 96-101.
34. Martins AS, Crescenzi A, Stern JE, Bordin S, Michelini LC. Hypertension and exercise training differentially affect oxytocin and oxytocin receptor expression in the brain. Hypertension 2005; 46: 1004-1009.
35. Babygirija R, Zheng J, Bülbül M, Ludwig K, Takahashi T. Beneficial effects of social attachment to overcome daily stress. Brain Res 2010; 1352: 43-49.
36. Veenema AH, Neumann ID. Central vasopressin and oxytocin release: regulation of complex social behaviours. Prog Brain Res 2008; 170: 261-276.
37. Zhu L, Onaka T. Involvement of medullary A2 noradrenergic neurons in the activation of oxytocin neurons after conditioned fear stimuli. Eur J Neurosci 2002; 16: 2186-2198.
38. Maruyama M, Matsumoto H, Fujiwara K, Noguchi J, Kitada C, Fujino M, Inoue K. Prolactin-releasing peptide as a novel stress mediator in the central nervous system. Endocrinology 2001; 142: 2032-2038.
39. Zhu LL, Onaka T. Facilitative role of prolactin-releasing peptide neurons in oxytocin cell activation after conditioned-fear stimuli. Neuroscience 2003; 118: 1045-1053.
40. Brown CH, Russell JA, Leng G. Opioid modulation of magnocellular neurosecretory cell activity. Neurosci Res 2000; 36: 97-120.
41. Dayas CV, Day TA. Opposing roles for medial and central amygdala in the initiation of noradrenergic cell responses to a psychological stressor. Eur J Neurosci 2002; 15: 1712-1718.
42. Masini CV, Sasse SK, Garcia RJ, Nyhuis TJ, Day HE, Campeau S. Disruption of neuroendocrine stress responses to acute ferret odor by medial, but not central amygdala lesions in rats. Brain Res 2009; 1288: 79-87.
43. Lin Y, Li X, Lupi M, Kinsey-Jones JS, Shao B, Lightman SL, O'Byrne KT. The role of the medial and central amygdala in stress-induced suppression of pulsatile LH secretion in female rats. Endocrinology 2011; 152: 545-555.
44. Verbalis JG, McCann MJ, McHale CM, Stricker EM. Oxytocin secretion in response to cholecystokinin and food: differentiation of nausea from satiety. Science 1986; 232: 1417-1419.
45. Renaud LP, Tang M, McCann MJ, Stricker EM, Verbalis JG. Cholecystokinin and gastric distension activate oxytocinergic cells in rat hypothalamus. Am J Physiol 1987; 253: R661-R665.
46. Flak JN, Jankord R, Solomon MB, Krause EG, Herman JP. Opposing effects of chronic stress and weight restriction on cardiovascular, neuroendocrine and metabolic function. Physiol Behav 2011; 104: 228-234.
47. Ohlsson B, Forsling ML, Rehfeld JF, Sjölund K. Cholecystokinin stimulation leads to increased oxytocin secretion in women. Eur J Surg 2002; 168: 114-118.
48. Verbalis JG, Richardson DW, Stricker EM. Vasopressin release in response to nausea-producing agents and cholecystokinin in monkeys. Am J Physiol Regu Physiol 1987; 252: R749-R753.
49. Chu K, Zingg HH. Activation of the mouse oxytocin promoter by the orphan receptor RORalpha. J Mol Endocrinol 1999; 23: 337-346.
50. Cantó C, Auwerx J. PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol 2009; 20: 98-105.
51. Ma D, Li S, Lucas EK, Cowell RM, Lin JD. Neuronal inactivation of peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) protects mice from diet-induced obesity and leads to degenerative lesions. J Biol Chem 2010; 285: 39087-39095.
52. Blechman J, Amir-Zilberstein L, Gutnick A, Ben-Dor S, Levkowitz G. The metabolic regulator PGC-1α directly controls the expression of the hypothalamic neuropeptide oxytocin. J Neurosci 2011; 31: 14835-14840.
53. Blouet C, Jo YH, Li X, Schwartz GJ. Mediobasal hypothalamic leucine sensing regulates food intake through activation of a hypothalamus-brainstem circuit. J Neurosci 2009; 29: 8302-8311.
54. Luckman SM. Fos-like immunoreactivity in the brainstem of the rat following peripheral administration of cholecystokinin. J Neuroendocrinol 1992; 4: 149-152.
55. Onaka T, Luckman SM, Antonijevic I, Palmer JR, Leng G. Involvement of the noradrenergic afferents from the nucleus tractus solitarii to the supraoptic nucleus in oxytocin release after peripheral cholecystokinin octapeptide in the rat. Neuroscience 1995; 66: 403-412.
56. Kendrick K, Leng G, Higuchi T. Noradrenaline, dopamine and serotonin release in the paraventricular and supraoptic nuclei of the rat in response to intravenous cholecystokinin injection. J Neuroendocrinol 1991; 3: 139-144.
57. Onaka T, Luckman SM, Guevara-Guzman R, Ueta Y, Kendrick K, Leng G. Presynaptic actions of morphine: blockade of cholecystokinin-induced noradrenaline release in the rat supraoptic nucleus. J Physiol 1995; 482: 69-79.
58. Ueta Y, Kannan H, Higuchi T, Negoro H, Yamashita H. CCK-8 excites oxytocin-secreting neurons in the paraventricular nucleus in rats--possible involvement of noradrenergic pathway. Brain Res Bull 1993; 32: 453-459.
59. Takayanagi Y, Matsumoto H, Nakata M, Mera T, Fukusumi S, Hinuma S, Ueta Y, Yada T, Leng G, Onaka T. Endogenous prolactin-releasing peptide regulates food intake in rodents. J Clin Invest 2008; 118: 4014-4024.
60. Lawrence CB, Ellacott KL, Luckman SM. PRL-releasing peptide reduces food intake and may mediate satiety signaling. Endocrinology 2002; 143: 360-367.
61. Uvnäs-Moberg K. Physiological and endocrine effects of social contact. Ann N Y Acad Sci 1997; 807: 146-163.
62. Strathearn L. Maternal neglect: oxytocin, dopamine and the neurobiology of attachment. J Neuroendocrinol 2011; 23: 1054-1065.
63. Winslow JT, Noble PL, Lyons CK, Sterk SM, Insel TR. Rearing effects on cerebrospinal fluid oxytocin concentration and social buffering in rhesus monkeys. Neuropsychopharmacology 2003; 28: 910-918.
64. Maestripieri D, Hoffman CL, Anderson GM, Carter CS, Higley JD. Mother-infant interactions in free-ranging rhesus macaques: relationships between physiological and behavioral variables. Physiol Behav 2009; 96: 613-619.
65. Gordon I, Zagoory-Sharon O, Leckman JF, Feldman R. Oxytocin and the development of parenting in humans. Biol Psychiatry 2010; 68: 377-382.
66. Kéri S, Kiss I. Oxytocin response in a trust game and habituation of arousal. Physiol Behav 2011; 102: 221-224.
67. Nagasawa M, Kikusui T, Onaka T, Ohta M. Dog's gaze at its owner increases owner's urinary oxytocin during social interaction. Horm Behav 2009; 55: 434-441.
68. Wang Y, Takayanagi Y, Onaka T. Roles of the medial amygdala in the control of social behaviour in mice. Neurosci Res 2011; 71(Suppl): e265.
69. Baskerville TA, Douglas AJ. Dopamine and oxytocin interactions underlying behaviors: potential contributions to behavioral disorders. CNS Neurosci Ther 2010; 16: e92-e123.
70. Windle RJ, Kershaw YM, Shanks N, Wood SA, Lightman SL, Ingram CD. Oxytocin attenuates stress-induced c-fos mRNA expression in specific forebrain regions associated with modulation of hypothalamo-pituitary-adrenal activity. J Neurosci 2004; 24: 2974-2982.
71. Neumann ID. Involvement of the brain oxytocin system in stress coping: interactions with the hypothalamo-pituitary-adrenal axis. Prog Brain Res 2002; 139: 147-162.
72. Neumann ID. Brain oxytocin: a key regulator of emotional and social behaviours in both females and males. J Neuroendocrinol 2008; 20: 858-865.
73. Yoshida M, Takayanagi Y, Inoue K, Kimura T, Young LJ, Onaka T, Nishimori K. Evidence that oxytocin exerts anxiolytic effects via oxytocin receptor expressed in serotonergic neurons in mice. J Neurosci 2009; 29: 2259-2271.
74. Chaviaras S, Mak P, Ralph D, Krishnan L, Broadbear JH. Assessing the antidepressant-like effects of carbetocin, an oxytocin agonist, using a modification of the forced swimming test. Psychopharmacology 2010; 210: 35-43.
75. Grippo AJ, Trahanas DM, Zimmerman RR II, Porges SW, Carter CS. Oxytocin protects against negative behavioral and autonomic consequences of long-term social isolation. Psychoneuroendocrinology 2009; 34: 1542-1553.
76. Ebner K, Bosch OJ, Krömer SA, Singewald N, Neumann ID. Release of oxytocin in the rat central amygdala modulates stress-coping behavior and the release of excitatory amino acids. Neuropsychopharmacology 2005; 30: 223-230.
77. Petersson M, Uvnäs-Moberg K. Effects of an acute stressor on blood pressure and heart rate in rats pretreated with intracerebroventricular oxytocin injections. Psychoneuroendocrinology 2007; 32: 959-965.
78. Amico JA, Mantella RC, Vollmer RR, Li X. Anxiety and stress responses in female oxytocin deficient mice. J Neuroendocrinol 2004; 16: 319-324.
79. Ditzen B, Schaer M, Gabriel B, Bodenmann G, Ehlert U, Heinrichs M. Intranasal oxytocin increases positive communication and reduces cortisol levels during couple conflict. Biol Psychiatry 2009; 65: 728-731.
80. Quirin M, Kuhl J, Düsing R. Oxytocin buffers cortisol responses to stress in individuals with impaired emotion regulation abilities. Psychoneuroendocrinology 2011; 36: 898-904.
81. Zheng J, Babygirija R, Bülbül M, Cerjak D, Ludwig K, Takahashi T. Hypothalamic oxytocin mediates adaptation mechanism against chronic stress in rats. Am J Physiol Gastrointest Liver Physiol 2010; 299: G946-G953.
82. Yoshimoto S, Cerjak D, Babygirija R, Bulbul M, Ludwig K, Takahashi T. Hypothalamic circuit regulating colonic transit following chronic stress in rats. Stress 2012; 15: 227-236.
83. Babygirija R, Bülbül M, Cerjak D, Ludwig K, Takahashi T. Sustained acceleration of colonic transit following chronic homotypic stress in oxytocin knockout mice. Neurosci Lett 2011; 495: 77-81.
84. Rodrigues SM, Saslow LR, Garcia N, John OP, Keltner D. Oxytocin receptor genetic variation relates to empathy and stress reactivity in humans. Proc Natl Acad Sci USA 2009; 106: 21437-21441.
85. Saphire-Bernstein S, Way BM, Kim HS, Sherman DK, Taylor SE. Oxytocin receptor gene (OXTR) is related to psychological resources. Proc Natl Acad Sci USA 2011; 108: 15118-15122.
86. Lucht MJ, Barnow S, Sonnenfeld C, Rosenberger A, Grabe HJ, Schroeder W, Völzke H, Freyberger HJ, Herrmann FH, Kroemer H, Rosskopf D. Associations between the oxytocin receptor gene (OXTR) and affect, loneliness and intelligence in normal subjects. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 860-866.
87. Tost H, Kolachana B, Hakimi S, Lemaitre H, Verchinski BA, Mattay VS, Weinberger DR, Meyer-Lindenberg A. A common allele in the oxytocin receptor gene (OXTR) impacts prosocial temperament and human hypothalamic-limbic structure and function. Proc Natl Acad Sci USA 2010; 107: 13936-13941.
88. Montag C, Fiebach CJ, Kirsch P, Reuter M. Interaction of 5-HTTLPR and a variation on the oxytocin receptor gene influences negative emotionality. Biol Psychiatry 2011; 69: 601-603.
89. Thompson RJ, Parker KJ, Hallmayer JF, Waugh CE, Gotlib IH. Oxytocin receptor gene polymorphism (rs2254298) interacts with familial risk for psychopathology to predict symptoms of depression and anxiety in adolescent girls. Psychoneuroendocrinology 2011; 36: 144-147.
90. Inoue H, Yamasue H, Tochigi M, Abe O, Liu X, Kawamura Y, Takei K, Suga M, Yamada H, Rogers MA, Aoki S, Sasaki T, Kasai K. Association between the oxytocin receptor gene and amygdalar volume in healthy adults. Biol Psychiatry 2010; 68: 1066-1072.
91. De Oca BM, DeCola JP, Maren S, Fanselow MS. Distinct regions of the periaqueductal gray are involved in the acquisition and expression of defensive responses. J Neurosci 1998; 18: 3426-3432.
92. Viviani D, Charlet A, van den Burg E, Robinet C, Hurni N, Abatis M, Magara F, Stoop R. Oxytocin selectively gates fear responses through distinct outputs from the central amygdala. Science 2011; 333: 104-107.
93. Kirsch P, Esslinger C, Chen Q, Mier D, Lis S, Siddhanti S, Gruppe H, Mattay VS, Gallhofer B, Meyer-Lindenberg A. Oxytocin modulates neural circuitry for social cognition and fear in humans. J Neurosci 2005; 25: 11489-11493.
94. Domes G, Heinrichs M, Gläscher J, Büchel C, Braus DF, Herpertz SC. Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biol Psychiatry 2007; 62: 1187-1190.
95. Petrovic P, Kalisch R, Singer T, Dolan RJ. Oxytocin attenuates affective evaluations of conditioned faces and amygdala activity. J Neurosci 2008; 28: 6607-6615.
96. Baumgartner T, Heinrichs M, Vonlanthen A, Fischbacher U, Fehr E. Oxytocin shapes the neural circuitry of trust and trust adaptation in humans. Neuron 2008; 58: 639-650.
97. Gamer M, Zurowski B, Büchel C. Different amygdala subregions mediate valence-related and attentional effects of oxytocin in humans. Proc Natl Acad Sci USA 2010; 107: 9400-9405.
98. Labuschagne I, Phan KL, Wood A, Angstadt M, Chua P, Heinrichs M, Stout JC, Nathan PJ. Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder. Neuropsychopharmacology 2010; 35: 2403-2413.
99. Onaka T, Ikeda K, Yamashita T, Honda K. Facilitative role of endogenous oxytocin in noradrenaline release in the rat supraoptic nucleus. Eur J Neurosci 2003; 18: 3018-3026.
100. Pagani JH, Lee HJ, Young WS III. Postweaning, forebrain-specific perturbation of the oxytocin system impairs fear conditioning. Genes Brain Behav 2011; 10: 710-719.
101. Blume A, Bosch OJ, Miklos S, Torner L, Wales L, Waldherr M, Neumann ID. Oxytocin reduces anxiety via ERK1/2 activation: local effect within the rat hypothalamic paraventricular nucleus. Eur J Neurosci 2008; 27: 1947-1956.
102. Ebner K, Wotjak CT, Landgraf R, Engelmann M. A single social defeat experience selectively stimulates the release of oxytocin, but not vasopressin, within the septal brain area of male rats. Brain Res 2000; 872: 87-92.
103. Cohen H, Kaplan Z, Kozlovsky N, Gidron Y, Matar MA, Zohar J. Hippocampal microinfusion of oxytocin attenuates the behavioural response to stress by means of dynamic interplay with the glucocorticoid-catecholamine responses. J Neuroendocrinol 2010; 22: 889-904.
104. Arletti R, Benelli A, Bertolini A. Oxytocin inhibits food and fluid intake in rats. Physiol Behav 1990; 48: 825-830.
105. Olson BR, Drutarosky MD, Stricker EM, Verbalis JG. Brain oxytocin receptor antagonism blunts the effects of anorexigenic treatments in rats: evidence for central oxytocin inhibition of food intake. Endocrinology 1991; 129: 785-791.
106. Zhang G, Cai D. Circadian intervention of obesity development via resting-stage feeding manipulation or oxytocin treatment. Am J Physiol Endocrinol Metab 2011; 301: E1004-E1012.
107. Morton GJ, Thatcher BS, Reidelberger RD, Ogimoto K, Wolden-Hanson T, Baskin DG, Schwartz MW, Blevins JE. Peripheral oxytocin suppresses food intake and causes weight loss in diet-induced obese rats. Am J Physiol Endocrinol Metab 2012; 302: E134-E144.
108. Swaab DF, Purba JS, Hofman MA. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases. J Clin Endocrinol Metab 1995; 80: 573-579.
109. Borg J, Simren M, Ohlsson B. Oxytocin reduces satiety scores without affecting the volume of nutrient intake or gastric emptying rate in healthy subjects. Neurogastroenterol Motil 2011; 23: 56-61.
110. Blevins JE, Schwartz MW, Baskin DG. Evidence that paraventricular nucleus oxytocin neurons link hypothalamic leptin action to caudal brain stem nuclei controlling meal size. Am J Physiol Regul Integr Comp Physiol 2004; 287: R87-R96.
111. Baskin DG, Kim F, Gelling RW, Russell BJ, Schwartz MW, Morton GJ, Simhan HN, Moralejo DH, Blevins JE. A new oxytocin-saporin cytotoxin for lesioning oxytocin-receptive neurons in the rat hindbrain. Endocrinology 2010; 151: 4207-4213.
112. Leng G, Onaka T, Caquineau C, Sabatier N, Tobin V, Takayanagi Y. Oxytocin and appetite. Prog Brain Res 2008; 170: 137-151.
113. Mantella RC, Rinaman L, Vollmer RR, Amico JA. Cholecystokinin and D-fenfluramine inhibit food intake in oxytocin-deficient mice. Am J Physiol Regul Integr Comp Physiol 2003; 285: R1037-R1045.
114. Takayanagi Y, Kasahara Y, Onaka T, Takahashi N, Kawada T, Nishimori K. Oxytocin receptor-deficient mice developed late-onset obesity. NeuroReport 2008; 19: 951-955.
115. Onaka T, Takayanagi Y, Leng G. Metabolic and stress-related roles of prolactin-releasing peptide. Trends Endocrinol Metab 2010; 21: 287-293.
116. Mera T, Fujihara H, Saito J, Kawasaki M, Hashimoto H, Saito T, Shibata M, Onaka T, Tanaka Y, Oka T, Tsuji S, Ueta Y. Downregulation of prolactin-releasing peptide gene expression in the hypothalamus and brainstem of diabetic rats. Peptides 2007; 28: 1596-1604.
117. Hâkansson ML, Brown H, Ghilardi N, Skoda RC, Meister B. Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. J Neurosci 1998; 18: 559-572.
118. Tung YC, Ma M, Piper S, Coll A, O'Rahilly S, Yeo GS. Novel leptin-regulated genes revealed by transcriptional profiling of the hypothalamic paraventricular nucleus. J Neurosci 2008; 28: 12419-12426.
119. Clark KA, Shin AC, Sirivelu MP, Mohankumar SM, Mohankumar PS. Systemic administration of leptin decreases plasma corticosterone levels: role of hypothalamic norepinephrine. Brain Res 2008; 1195: 89-95.
120. Caquineau C, Douglas AJ, Leng G. Effects of cholecystokinin in the supraoptic nucleus and paraventricular nucleus are negatively modulated by leptin in 24-h fasted lean male rats. J Neuroendocrinol 2010; 22: 446-452.
121. Kutlu S, Aydin M, Alcin E, Ozcan M, Bakos J, Jezova D, Yilmaz B. Leptin modulates noradrenaline release in the paraventricular nucleus and plasma oxytocin levels in female rats: a microdialysis study. Brain Res 2010; 1317: 87-91.
122. Velmurugan S. Actions of appetite regulating peptides on supraoptic nucleus (SON) oxytocin neurons. PhD by Research, University of Edinburgh. Edinburgh, 2009.
123. Rinaman L, Vollmer RR, Karam J, Phillips D, Li X, Amico JA. Dehydration anorexia is attenuated in oxytocin-deficient mice. Am J Physiol Regul Integr Comp Physiol 2005; 288: R1791-R1799.
124. Gaetani S, Fu J, Cassano T, Dispasquale P, Romano A, Righetti L, Cianci S, Laconca L, Giannini E, Scaccianoce S, Mairesse J, Cuomo V. The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin. J Neurosci 2010; 30: 8096-8101.
125. Ladyman SR, Sapsford TJ, Grattan DR. Loss of acute satiety response to cholecystokinin in pregnant rats. J Neuroendocrinol 2011; 23: 1091-1098.
126. Douglas AJ, Johnstone LE, Leng G. Neuroendocrine mechanisms of change in food intake during pregnancy: a potential role for brain oxytocin. Physiol Behav 2007; 91: 352-365.
127. Brunton PJ, Russell JA. Endocrine induced changes in brain function during pregnancy. Brain Res 2010; 1364: 198-215.
128. Olszewski PK, Klockars A, Schiöth HB, Levine AS. Oxytocin as feeding inhibitor: maintaining homeostasis in consummatory behavior. Pharmacol Biochem Behav 2010; 97: 47-54.
129. Olszewski PK, Klockars A, Olszewska AM, Fredriksson R, Schiöth HB, Levine AS. Molecular, immunohistochemical, and pharmacological evidence of oxytocin's role as inhibitor of carbohydrate but not fat intake. Endocrinology 2010; 151: 4736-4744.
130. Sclafani A, Rinaman L, Vollmer RR, Amico JA. Oxytocin knockout mice demonstrate enhanced intake of sweet and nonsweet carbohydrate solutions. Am J Physiol Regul Integr Comp Physiol 2007; 292: R1828-R1833.
131. Lee HJ, Caldwell HK, Macbeth AH, Tolu SG, Young WS III. A conditional knockout mouse line of the oxytocin receptor. Endocrinology 2008; 149: 3256-3263.
132. Shahrokh DK, Zhang TY, Diorio J, Gratton A, Meaney MJ. Oxytocin-dopamine interactions mediate variations in maternal behavior in the rat. Endocrinology 2010; 151: 2276-2286.
133. Takayanagi Y, Nishimori K, Onaka T. Role of oxytocin receptors in the control of stress-induced energy expenditure. Proceedings of the 8th World Congress on Neurohypophyseal Hormones (WCNH), Kitakyushu, Japan, 2009; 91-92.
134. Camerino C. Low sympathetic tone and obese phenotype in oxytocin-deficient mice. Obesity (Silver Spring) 2009; 17: 980-984.
135. Rinaman L, Rothe EE. GLP-1 receptor signaling contributes to anorexigenic effect of centrally administered oxytocin in rats. Am J Physiol Regul Integr Comp Physiol 2002; 283: R99-R106.
136. Maejima Y, Sedbazar U, Suyama S, Kohno D, Onaka T, Takano E, Yoshida N, Koike M, Uchiyama Y, Fujiwara K, Yashiro T, Horvath TL, Dietrich MO, Tanaka S, Dezaki K, Oh-I S, Hashimoto K, Shimizu H, Nakata M, Mori M, Yada T. Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway. Cell Metab 2009; 10: 355-365.
137. Lee HJ, Macbeth AH, Pagani JH, Young WS III. Oxytocin: the great facilitator of life. Prog Neurobiol 2009; 88: 127-151.
138. Neumann ID. The advantage of social living: brain neuropeptides mediate the beneficial consequences of sex and motherhood. Front Neuroendocrinol 2009; 30: 483-496.
139. Ross HE, Young LJ. Oxytocin and the neural mechanisms regulating social cognition and affiliative behavior. Front Neuroendocrinol 2009; 30: 534-547.
140. Insel TR. The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior. Neuron 2010; 65: 768-779.
141. Bosch OJ, Neumann ID. Both oxytocin and vasopressin are mediators of maternal care and aggression in rodents: from central release to sites of action. Horm Behav 2011; doi:.
142. Bartz JA, Zaki J, Bolger N, Ochsner KN. Social effects of oxytocin in humans: context and person matter. Trends Cogn Sci 2011; 15: 301-309.
143. Meyer-Lindenberg A, Domes G, Kirsch P, Heinrichs M. Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Rev Neurosci 2011; 12: 524-538.
144. Kogan A, Saslow LR, Impett EA, Oveis C, Keltner D, Rodrigues Saturn S. Thin-slicing study of the oxytocin receptor (OXTR) gene and the evaluation and expression of the prosocial disposition. Proc Natl Acad Sci USA 2011; 108: 19189-19192.
145. Bakermans-Kranenburg MJ, van Ijzendoorn MH. Oxytocin receptor (OXTR) and serotonin transporter (5-HTT) genes associated with observed parenting. Soc Cogn Affect Neurosci 2008; 3: 128-134.
146. Chen FS, Kumsta R, von Dawans B, Monakhov M, Ebstein RP, Heinrichs M. Common oxytocin receptor gene (OXTR) polymorphism and social support interact to reduce stress in humans. Proc Natl Acad Sci USA 2011; 108: 19937-19942.
147. Walum H, Lichtenstein P, Neiderhiser JM, Reiss D, Ganiban JM, Spotts EL, Pedersen NL, Anckarsäter H, Larsson H, Westberg L. Variation in the oxytocin receptor gene is associated with pair-bonding and social behavior. Biol Psychiatry 2012; 71: 419-426.
148. Liu X, Kawamura Y, Shimada T, Otowa T, Koishi S, Sugiyama T, Nishida H, Hashimoto O, Nakagami R, Tochigi M, Umekage T, Kano Y, Miyagawa T, Kato N, Tokunaga K, Sasaki T. Association of the oxytocin receptor (OXTR) gene polymorphisms with autism spectrum disorder (ASD) in the Japanese population. J Hum Genet 2010; 55: 137-141.
149. Liu Y, Wang ZX. Nucleus accumbens oxytocin and dopamine interact to regulate pair bond formation in female prairie voles. Neuroscience 2003; 121: 537-544.
150. Pedersen CA, Caldwell JD, Walker C, Ayers G, Mason GA. Oxytocin activates the postpartum onset of rat maternal behavior in the ventral tegmental and medial preoptic areas. Behav Neurosci 1994; 108: 1163-1171.
151. Samuelsen CL, Meredith M. Oxytocin antagonist disrupts male mouse medial amygdala response to chemical-communication signals. Neuroscience 2011; 180: 96-104.
152. Ferguson JN, Aldag JM, Insel TR, Young LJ. Oxytocin in the medial amygdala is essential for social recognition in the mouse. J Neurosci 2001; 21: 8278-8285.
153. Choleris E, Little SR, Mong JA, Puram SV, Langer R, Pfaff DW. Microparticle-based delivery of oxytocin receptor antisense DNA in the medial amygdala blocks social recognition in female mice. Proc Natl Acad Sci USA 2007; 104: 4670-4675.
154. Popik P, Vos PE, Van Ree JM. Neurohypophyseal hormone receptors in the septum are implicated in social recognition in the rat. Behav Pharmacol 1992; 3: 351-358.
155. Popik P, van Ree JM. Oxytocin but not vasopressin facilitates social recognition following injection into the medial preoptic area of the rat brain. Eur Neuropsychopharmacol 1991; 1: 555-560.
156. Dluzen DE, Muraoka S, Engelmann M, Ebner K, Landgraf R. Oxytocin induces preservation of social recognition in male rats by activating alpha-adrenoceptors of the olfactory bulb. Eur J Neurosci 2000; 12: 760-766.
157. van Wimersma Greidanus TB, Maigret C. The role of limbic vasopressin and oxytocin in social recognition. Brain Res 1996; 713: 153-159.
158. Ludwig M, Leng G. Dendritic peptide release and peptide-dependent behaviours. Nat Rev Neurosci 2006; 7: 126-136.
159. Leng G, Ludwig M. Neurotransmitters and peptides: whispered secrets and public announcements. J Physiol 2008; 586: 5625-5632.